All Cell Content

Bringing you the latest research surrounding the safety, efficacy and characterisation of cell & gene therapies, targeted approaches for cell line development, optimised cell media techniques, and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Insight Article
Will 3D model development reach its potential to innovate cell and gene therapeutics? We spoke to Merck, GlaxoSmithKline, East Carolina University Brody School of Medicine, and the Institute of Molecular Biotechnology to find out more.
By Tia Byer |
29 April 2022
Tissue Engineering & 3D Models
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our April Discussion Group addressing ‘3D Model Development’ brought together an exclusive panel of key opinion leaders to address the market’s growth and future directions.
By Tia Byer |
28 April 2022
Tissue Engineering & 3D Models
Commentary
Raymond R. Mattingly explains the applications of 3D cell culturing at Oxford Global’s 3D Cell Culture Symposium.
By Tom Cohen |
24 April 2022
Tissue Engineering & 3D Models
Commentary
This Commentary piece explores how the production and delivery of NK cells could provide a new option for clinical treatment of illnesses such as myeloid leukaemia, with the potential for scaling approaches to be incorporated into the treatment process.
By Ben Norris |
24 March 2022
Cell Therapy Development
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our February Discussion Group addressing ‘Cell Line Engineering’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
By Tia Byer |
23 March 2022
Cell Line Development & Engineering
Insight Article
Can the cell and gene therapy field create industry consensus on a more detailed level? In this Insight Article, Jorgen Magnus, Strategic Program Lead of Cell and Gene Therapy at Bayer, highlights the promise of process mapping for reaching a harmonised approach to development and manufacturing standards.
By Tia Byer |
17 March 2022
Gene Therapy Development
Insight Article
Emerging experts in the field of cell therapy: Emily Warner, Moin Saleem, and John Maher, answer questions about their science and industry
07 March 2022
Cell Therapy Development
Insight Article
The need to demonstrate clonality for regulatory approval means that now more than ever, the industry must look towards streamlining and optimising clone selection efficacy. We sat down with senior representatives from Ichnos Sciences and Sanofi to learn how.
By Tia Byer |
28 February 2022
Cell Line Development & Engineering
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our January Discussion Group addressing ‘Streamlining Stem Cell Manufacturing’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
By Tia Byer |
03 February 2022
Cell & Gene Therapy Manufacturing
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our November Discussion Group addressing ‘Advancing The Implementation Of Automation Technologies For Cell Therapy Development’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
By Tia Byer |
31 January 2022
Cell Therapy Development

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login